Recombinant Sars-Cov2 Rbd Antigens

SARS-CoV2 RBD

0571-001 100 ug
EUR 395

Human IgG antibody Laboratories manufactures the recombinant sars-cov2 rbd antigens reagents distributed by Genprice. The Recombinant Sars-Cov2 Rbd Antigens reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SARS Recombinant. Other Recombinant products are available in stock. Specificity: Recombinant Category: Sars-Cov2 Group: Rbd Antigens

SARS-Cov2-NP2-Antibody

N/A
EUR 276.5
Description: N/A

SARS-Cov2-NP1-Antibody

N/A
EUR 276.5
Description: N/A

SARS-Cov2-NP1-Antibody

N/A
EUR 276.5
Description: N/A

SARS-CoV2-N-Antibody

N/A
EUR 276.5
Description: N/A

SARS-CoV2-N-Antibody

N/A
EUR 276.5
Description: N/A

Human anti-SARS-CoV2(N) IgG ELISA Kit

48T
EUR 400.4

Human anti-SARS-CoV2(N) IgG ELISA Kit

5x96T
EUR 2717

Rbd Antigens information

Human SARS-CoV-2 (COVID-19) S Recombinant Protein RBD His Tag

IHUCOV2SRHIS200UG each
EUR 1338
Description: Human SARS-CoV-2 (COVID-19) S Recombinant Protein RBD His Tag

Recombinant SARS-CoV-2 Spike RBD

AP60510 each Ask for price

Recombinant SARS-CoV Spike/RBD Protein (RBD, His Tag)

PKSV030251-100ug 100ug
EUR 1105
Description: SARS

Recombinant SARS-CoV Spike/RBD Protein (RBD, rFc Tag)

PKSV030253-100ug 100ug
EUR 1105
Description: SARS

SARS Spike RBD Recombinant Protein

10-211 0.1 mg
EUR 651.3
Description: The spike protein (S) of coronavirus (CoV) attaches the virus to its cellular receptor, angiotensinconverting enzyme 2 (ACE2). A defined receptor-binding domain (RBD) on S mediates this interaction.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.

Recombinant SARS-CoV Spike RBD Protein

RP02481 500μg
EUR 243.75

Recombinant SARS SARS Spike RBD Protein, Avi His Tag

E40KMP2110 20ug
EUR 495

SARS-CoV-2 (COVID-19) Spike-RBD Recombinant Protein

10-015 0.1 mg
EUR 714.3
Description: SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) also known as 2019-nCoV (2019 Novel Coronavirus) is a virus that causes illnesses ranging from the common cold to severe diseases. SARS CoV-2 spike protein is composed of S1 domain and S2 domain. S1 contains a receptor-binding domain (RBD) that can specifically bind to angiotensin-converting enzyme 2 (ACE2), the receptor on the target cells. SARS-CoV-2 spike protein (RBD) has the potential value for the diagnosis of the virus.

SARS-CoV-2 (COVID-19) Spike-RBD Recombinant Protein

10-008 0.1 mg
EUR 714.3
Description: SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) also known as 2019-nCoV (2019 Novel Coronavirus) is a virus that causes illnesses ranging from the common cold to severe diseases. SARS CoV-2 spike protein is composed of S1 domain and S2 domain. S1 contains a receptor-binding domain (RBD) that can specifically bind to angiotensin-converting enzyme 2 (ACE2), the receptor on the target cells. SARS-CoV-2 spike protein (RBD) has the potential value for the diagnosis of the virus.

SARS-CoV-2 (COVID-19) Variant Spike Protein RBD (E484D) Recombinant Protein

21-829 0.1 mg
EUR 714.3
Description: SARS-CoV-2 (COVID-19) Variant Spike Protein RBD (E484D) Recombinant Protein

SARS-CoV-2 (COVID-19) UK variant (B.1.1.7) S RBD (N501Y) Recombinant Protein

11-064 0.1 mg
EUR 714.3
Description: Protein S (PROS1) is glycoprotein and expressed in many cell types supporting its reported involvement in multiple biological processes that include coagulation, apoptosis, cancer development and progression, and the innate immune response. Known receptors bind S1 are ACE2, angiotensin-converting enzyme 2, DPP4, CEACAM etc.. The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. Most notable is severe acute respiratory syndrome (SARS). The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike (S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogen and a target for entry inhibitors. It's been reported that 2019-nCoV can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.

SARS-CoV-2 (COVID-19) UK variant (B.1.1.7) S RBD (N501Y) Recombinant Protein

11-069 0.1 mg
EUR 651.3
Description: The spike protein (S) of coronavirus (CoV) attaches the virus to its cellular receptor, angiotensin-converting enzyme 2 (ACE2). A defined receptor-binding domain (RBD) on S mediates this interaction. The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.

SARS-CoV-2 (COVID-19) Spike RBD Recombinant Protein C-terminal His Tag

ICOV2STRBDRCHIS100UG each
EUR 738
Description: SARS-CoV-2 (COVID-19) Spike RBD Recombinant Protein C-terminal His Tag

SARS-CoV-2 (COVID-19) Omicron Variant (B.1.1.529) Spike RBD Recombinant Protein

21-844 0.1 mg
EUR 714.3
Description: Protein S (PROS1) is glycoprotein and expressed in many cell types supporting its reported involvement in multiple biologicalprocesses that include coagulation, apoptosis, cancer development and progression, and the innate immune response. Knownreceptors bind S1 are ACE2, angiotensin-converting enzyme 2, DPP4, CEACAM etc.. The spike (S) glycoprotein ofcoronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. Mostnotable is severe acute respiratory syndrome (SARS). The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike(S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogenand a target for entry inhibitors. It's been reported that 2019-nCoV can infect the human respiratory epithelial cells throughinteraction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits,S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor.S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizingantibodyand T-cell responses, as well as protective immunity.

Recombinant SARS-COV-2 Spike RBD Protein

RP02325 500μg
EUR 266.5

Recombinant SARS-COV-2 Spike RBD Protein

RP02332 500μg
EUR 243.75

SARS-CoV-2 (COVID-19) Beta Variant ( B.1.351, SA) Spike RBD Recombinant Protein

21-825 0.1 mg
EUR 1186.8
Description: All viruses undergo fast mutations and adept quickly to the countermeasures that the immune systems creates against them. SARS-CoV-2 of the COVID-19 pandemic is no exception here. During the pandemic multiple mutant strains arose. To help the science combat these mutants ProSci offers the RB-Domains of these mutant SPIKE proteins. That is the full Receptor-Binding Domain of the SPIKE surface protein SARS-CoV-2 of the mutant strain B.1.351, also commonly known as the "SA / South Africa mutant".